13D/G large-stake feed

Latest 13D/G Reports

Since 29 May 2026. Review filer CIK, subject security, ownership %, and SEC evidence first.

Recent 13D/G signals

Large-stake disclosures to inspect

Start with holder, issuer/security, stake size, and SEC evidence.

13D/A

SINO LION VENTURES Ltd stake in Indaptus Therapeutics, Inc.

Holder CIK 0002120638

13D/A INDP
CIK
0002120638
Issuer
Indaptus Therapeutics, Inc.
Security
INDP
Source
SEC 13D/A
Action
Beneficial ownership disclosure
Magnitude
29% / 38,895,000 shares
Filed
26 Jun 2026, 21:40:03 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13D/A

Applied Digital Corp. stake in ChronoScale Corp

Holder CIK 0001144879

13D/A CHRN
CIK
0001144879
Issuer
ChronoScale Corp
Security
CHRN
Source
SEC 13D/A
Action
Beneficial ownership disclosure
Magnitude
96% / 139,528,227 shares
Filed
26 Jun 2026, 21:30:01 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13D/A

Dai Junyi stake in Indaptus Therapeutics, Inc.

Holder CIK 0002022463

13D/A INDP
CIK
0002022463
Issuer
Indaptus Therapeutics, Inc.
Security
INDP
Source
SEC 13D/A
Action
Beneficial ownership disclosure
Magnitude
8.4% / 11,250,000 shares
Filed
26 Jun 2026, 20:00:28 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13D/A

Yang Ting stake in Indaptus Therapeutics, Inc.

Holder CIK 0002120636

13D/A INDP
CIK
0002120636
Issuer
Indaptus Therapeutics, Inc.
Security
INDP
Source
SEC 13D/A
Action
Beneficial ownership disclosure
Magnitude
8.4% / 11,250,000 shares
Filed
26 Jun 2026, 20:00:07 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13D/A

Yao Yun stake in Indaptus Therapeutics, Inc.

Holder CIK 0002120637

13D/A INDP
CIK
0002120637
Issuer
Indaptus Therapeutics, Inc.
Security
INDP
Source
SEC 13D/A
Action
Beneficial ownership disclosure
Magnitude
32% / 41,991,000 shares
Filed
26 Jun 2026, 20:00:01 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13D

Brown Jameson Pruitt stake in NEW ENGLAND REALTY ASSOCIATES LIMITED PARTNERSHIP

Holder CIK 0001814042

13D NEN
CIK
0001814042
Issuer
NEW ENGLAND REALTY ASSOCIATES LIMITED PARTNERSHIP
Security
NEN
Source
SEC 13D
Action
Beneficial ownership disclosure
Magnitude
32% / 878,529 shares
Filed
26 Jun 2026, 18:55:41 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

Rows shown
1-50 of 955
Per page
50
Current page
1

Schedule 13D/G ownership events

Activist and large-stake radar

Stake size, change direction, reporting filer, issuer, active/passive form type, and SEC evidence.

Visible reports

6

Fresh large-stake filings promoted above the legacy table.

13D/13G mix

6/0

Active-intent candidates versus passive large-stake disclosures.

Largest visible stake

96%

Highest class ownership surfaced in the preview cards.

Newest evidence

26 Jun 2026

Use recency before treating an old large-stake story as fresh.

Signal checks

13D active-intent check

active/control intent, item text, amendments

13G passive stake check

large passive holder disclosure

Stake change direction

ownership percent and share change

Issuer and owner follow-up

issuer, filer history, insider activity, 13F context

SEC-verifiable Schedule 13D/G path

Open the Schedule 13D/G filing, then cross-check insider and Form 13F evidence.

Large-stake signal

SINO LION VENTURES Ltd

Indaptus Therapeutics, Inc. (INDP)

Schedule 13D/A Ownership 29% Filing-backed
CIK
000182912626006953
Source
SEC Schedule 13D/A
Action
Potential activist/control stake disclosed
Magnitude
29%
Filed
26 Jun 2026, 21:40:03 UTC
Period
24 Jun 2026

SINO LION VENTURES Ltd filed Schedule 13D/A for Indaptus Therapeutics, Inc. (INDP). Reported class ownership: 29%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

Applied Digital Corp.

ChronoScale Corp (CHRN)

Schedule 13D/A Ownership 96% Filing-backed
CIK
000149315226030373
Source
SEC Schedule 13D/A
Action
Potential activist/control stake disclosed
Magnitude
96%
Filed
26 Jun 2026, 21:30:01 UTC
Period
26 Jun 2026

Applied Digital Corp. filed Schedule 13D/A for ChronoScale Corp (CHRN). Reported class ownership: 96%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

Dai Junyi

Indaptus Therapeutics, Inc. (INDP)

Schedule 13D/A Ownership 8.4% Filing-backed
CIK
000182912626006951
Source
SEC Schedule 13D/A
Action
Potential activist/control stake disclosed
Magnitude
8.4%
Filed
26 Jun 2026, 20:00:28 UTC
Period
24 Jun 2026

Dai Junyi filed Schedule 13D/A for Indaptus Therapeutics, Inc. (INDP). Reported class ownership: 8.4%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

Yang Ting

Indaptus Therapeutics, Inc. (INDP)

Schedule 13D/A Ownership 8.4% Filing-backed
CIK
000182912626006950
Source
SEC Schedule 13D/A
Action
Potential activist/control stake disclosed
Magnitude
8.4%
Filed
26 Jun 2026, 20:00:07 UTC
Period
24 Jun 2026

Yang Ting filed Schedule 13D/A for Indaptus Therapeutics, Inc. (INDP). Reported class ownership: 8.4%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

Yao Yun

Indaptus Therapeutics, Inc. (INDP)

Schedule 13D/A Ownership 32% Filing-backed
CIK
000182912626006949
Source
SEC Schedule 13D/A
Action
Potential activist/control stake disclosed
Magnitude
32%
Filed
26 Jun 2026, 20:00:01 UTC
Period
24 Jun 2026

Yao Yun filed Schedule 13D/A for Indaptus Therapeutics, Inc. (INDP). Reported class ownership: 32%. Ownership change: -5.6%. Share change: 0%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

Brown Jameson Pruitt

NEW ENGLAND REALTY ASSOCIATES LIMITED PARTNERSHIP (NEN)

Schedule 13D Ownership 32% Filing-backed
CIK
000110465926078371
Source
SEC Schedule 13D
Action
Potential activist/control stake disclosed
Magnitude
32%
Filed
26 Jun 2026, 18:55:41 UTC
Period
26 Jun 2026

Brown Jameson Pruitt filed Schedule 13D for NEW ENGLAND REALTY ASSOCIATES LIMITED PARTNERSHIP (NEN). Reported class ownership: 32%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Filed by Symbol Subject Shares owned Ownership % Source
SINO LION VENTURES Ltd CIK 0002120638 INDP Indaptus Therapeutics, Inc. 38,895,000 29% SEC filing
Applied Digital Corp. CIK 0001144879 CHRN ChronoScale Corp 139,528,227 96% SEC filing
Dai Junyi CIK 0002022463 INDP Indaptus Therapeutics, Inc. 11,250,000 8.4% SEC filing
Yang Ting CIK 0002120636 INDP Indaptus Therapeutics, Inc. 11,250,000 8.4% SEC filing
Yao Yun CIK 0002120637 INDP Indaptus Therapeutics, Inc. 41,991,000 32% SEC filing
Brown Jameson Pruitt CIK 0001814042 NEN NEW ENGLAND REALTY ASSOCIATES LIMITED PARTNERSHIP 878,529 32% SEC filing
WHITEBOX ADVISORS LLC CIK 0001257391 MAXNQ Maxeon Solar Technologies, Ltd. 1,591,596 8.5% SEC filing
BIOTECHNOLOGY VALUE FUND L P CIK 0000918923 KYMR Kymera Therapeutics, Inc. 5,237,151 6.3% SEC filing
WOJCIK JERZY STANISLAW CIK 0002142675 ADTX Aditxt, Inc. 160,144 20% SEC filing
Bradley & Daytona Railway & Land Co. LLC CIK 0002005138 PWPRA Power REIT 15,670 4.7% SEC filing
Swenson Nicholas John CIK 0001478067 PDEX PRO-DEX, INC. 1,017,817 32% SEC filing
Spark Capital Growth Fund III, L.P. CIK 0001767515 CUSIP 87821B109 Teamshares Inc. 3,645,439 5.1% SEC filing
WBR Holdings LLC CIK 0002086161 WBI WaterBridge Infrastructure LLC 53,743,584 52% SEC filing
RA CAPITAL MANAGEMENT, L.P. CIK 0001346824 HOWL WEREWOLF THERAPEUTICS, INC. 2,915,742 6% SEC filing
MORGAN STANLEY CIK 0000895421 ZEPP Zepp Health Corp 8,472,224 7.5% SEC filing
MILLENNIUM MANAGEMENT LLC CIK 0001273087 LENZ LENZ Therapeutics, Inc. 1,603,512 5.1% SEC filing
Eclipse Continuity GP I, LLC CIK 0001675124 CUSIP US15675D1037 Cerebras Systems, Inc. 11,580,218 5.2% SEC filing
CHURCHILL SPONSOR XI LLC CIK 0002078043 CCXIU Churchill Capital Corp XI 14,300,000 26% SEC filing
Scilex Holding Co CIK 0001820190 SMNRW Semnur Pharmaceuticals, Inc. 181,520,112 79% SEC filing
Catheter Precision, Inc. CIK 0001716621 SOAR Volato Group, Inc. 2,941,176 7.5% SEC filing
Wave Factorial Energy I, LLC CIK 0001906529 CUSIP 30347G103 Factorial Energy Inc. 11,474,452 11% SEC filing
Khosla Ventures VII, L.P. CIK 0001828214 CUSIP 87821B109 Teamshares Inc. 7,498,171 10% SEC filing
USV 2019, LP CIK 0001762444 CUSIP 87821B109 Teamshares Inc. 2,378,671 3.3% SEC filing
QED Growth Fund, LP CIK 0001869244 CUSIP 87821B109 Teamshares Inc. 5,992,667 8.3% SEC filing
Comer James Lamar Walton CIK 0002123991 RVYL RTB Digital, Inc 4,504,276 32% SEC filing
Waldencast Long-Term Capital LLC CIK 0001840220 WALD Waldencast plc 0 0% SEC filing
Paradigm Biocapital Advisors LP CIK 0001855655 VRDN Viridian Therapeutics, Inc. 5,633,788 5.1% SEC filing
Millstreet Capital Management LLC CIK 0001590729 CUSIP 0000000000 DIEBOLD NIXDORF, Inc 4,204,432 12% SEC filing
MMCAP International Inc. SPC CIK 0001304857 CUSIP G9640P104 Wilco 63 Corp 1,500,000 6.5% SEC filing
CAPITAL VENTURES INTERNATIONAL CIK 0001011712 QNC Quantum eMotion Corp. 24,234,055 11% SEC filing
CVI Investments, Inc. CIK 0001649553 CRVO CervoMed Inc. 750,000 5.5% SEC filing
Glory Achievement Fund Ltd CIK 0001764895 NIU Niu Technologies 64,018,111 41% SEC filing
FARALLON CAPITAL MANAGEMENT, L.L.C. CIK 0000909661 CNTA Centessa Pharmaceuticals plc 0 0% SEC filing
Feis Equities LLC CIK 0001891626 DMAA Drugs Made In America Acquisition Corp. 1,232,775 5.1% SEC filing
OSN Streaming Ltd CIK 0002018653 ANGH Anghami Inc 7,417,345 71% SEC filing
Warner Bros. Discovery, Inc. CIK 0001437107 ANGH Anghami Inc. 7,417,345 71% SEC filing
Mountain Crest Holdings 6 LLC CIK 0002116124 CUSIP G62980100 Mountain Crest Acquisition 6 Corp. 2,596,429 30% SEC filing
ICS OPPORTUNITIES, LTD. CIK 0001487118 HQ Horizon Quantum Holdings Ltd. 20,632 0.1% SEC filing
Baselake Partners, LP CIK 0001957912 PASG Passage Bio, Inc. 235,058 7.3% SEC filing
Takeover Time 2026 LLC CIK 0002107788 ADTX Aditxt, Inc. 0 0% SEC filing
EcoR1 Capital, LLC CIK 0001587114 FULC Fulcrum Therapeutics, Inc. 6,000,000 9% SEC filing
EcoR1 Capital, LLC CIK 0001587114 FULC Fulcrum Therapeutics, Inc. 6,000,000 9% SEC filing
MILLENNIUM MANAGEMENT LLC CIK 0001273087 XNDU Xanadu Quantum Technologies Limited 82,694 0.2% SEC filing
Philotimo Fund, LP CIK 0001688522 ALLT Allot Ltd. 4,793,041 9.8% SEC filing
Les Filles, LLC CIK 0002141847 SRXH SRX Global Inc. 78,178,797 6.2% SEC filing
Avenue Venture Opportunities Fund II, L.P. CIK 0001886343 CALC CALCIMEDICA, INC. 4,641,163 5% SEC filing
GLAZER CAPITAL, LLC CIK 0001076809 ALOT AstroNova, Inc. 449,920 5.8% SEC filing
Bleichroeder LP CIK 0001781002 INVE Identiv, Inc. (INVE) 5,247,467 20% SEC filing
Sculptor Capital LP CIK 0001054587 CUSIP G9640P120 Wilco 63 Corporation 1,193,500 5.2% SEC filing
STEEL PARTNERS HOLDINGS L.P. CIK 0001452857 SPRU SPRUCE POWER HOLDING CORP 3,429,380 19% SEC filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .